Daniel P. Uccello
Pfizer (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Chemical Synthesis and Analysis, Synthesis and Catalytic Reactions, Ubiquitin and proteasome pathways, Crystallization and Solubility Studies
Most-Cited Works
- → Delineating the role of cooperativity in the design of potent PROTACs for BTK(2018)413 cited
- → Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors(2014)322 cited
- → Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes(2020)110 cited
- → Pyridone Methylsulfone Hydroxamate LpxC Inhibitors for the Treatment of Serious Gram-Negative Infections(2012)97 cited
- → Potent Inhibitors of LpxC for the Treatment of Gram-Negative Infections(2011)97 cited
- → Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation(2018)79 cited
- → Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)(2015)68 cited
- → Intrinsic reactivity profile of electrophilic moieties to guide covalent drug design: N-α-acetyl-l-lysine as an amine nucleophile(2016)63 cited
- → One-Pot Oxidation and Rearrangement of Propargylamines andin SituPyrazole Synthesis(2014)44 cited
- → Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family(2016)39 cited